Insider Purchases: Inside the Buy
Tag: featured-insiders
The “WTW” Strategy Scorecard: Why the Smart Money Is Huddled Here
Willis Towers Watson isn’t a hype stock—it’s a fortress. With insider buying, 100%+ institutional ownership, surging margins, and massive buybacks, WTW is quietly becoming one of the smartest “sleep-well” investments of 2026.
CHRW 2026: The “Karaoke Crash” and the Many Insiders “Buy-The-Dips”
A tiny “AI logistics” headline sparked a selloff in C.H. Robinson (CHRW). Insiders responded by buying. Is this a fear-driven dip or a signal that Lean AI is turning logistics into a margin machine?
Mattel’s Post-Earnings Fire Sale: A $1M Bet on the “Barbie Hangover” Recovery
Mattel’s stock just fell off the shelf after earnings—but CEO Ynon Kreiz responded by buying over $1M worth of shares. With iconic brands, massive buybacks, and a pivot toward digital and IP, is this a classic turnaround or just a nostalgic value trap? Let’s open the toy box and find out.
KKR: The Private Equity Giant Offering Public-Scale Prosperity
KKR is no longer just for billionaires in wood-paneled boardrooms. With insiders buying, earnings compounding, and shares still ~38% below highs, the private equity giant looks like public-scale opportunity.
The Great Data Detective: Is Varonis Solving Crimes or Just Finding Them?
Varonis’s stock chart looks like a crime scene—but insiders are buying, institutions are piled in, and the company sits at the center of AI data security. Is VRNS a value trap… or a comeback case file in the making?
Band-Aids & Bottom Lines: Why Kimberly-Clark’s 5% Yield Is the Ultimate Turnaround Play
KMB isn’t flashy—but it might be one of 2026’s sneakiest high-yield turnarounds. A $1M insider buy, heavy institutional ownership, and a big strategic pivot (hello, Tylenol & Band-Aids via Kenvue) have the market nervous… and contrarians intrigued.
The $2.4 Million Fry: Why Lamb Weston’s New Chair Is Buying the Dip You Shouldn’t Ignore
Lamb Weston is selling more fries for less—and the market hates it. But its new Executive Chair just dropped $2.4M of his own cash on the stock. Is this a soggy-fry value trap or the start of a crispy turnaround? Let’s decode the volume-vs-margin war. 🍟📊
Monro’s Pivot: From Aggressive Expansion to Margin Optimization
Monro cut 145 underperforming stores, lifted margins, and still pays a 5.5% dividend—while the CEO and Carl Icahn buy shares. A slow-burn, high-yield turnaround story in an aging-car economy.
Lumen Technologies: The Turnaround Nobody Believed (But the CEO Keeps Adding)
Lumen was left for dead—then the CEO kept buying, debt vanished, and AI demand showed up. A fun, honest look at LUMN’s comeback, risks, and why the stock may need a breather before the next sprint.
Enphase Energy: The Comeback Nobody Believed (But the CEO Keeps Buying)
Enphase Energy fell hard after its solar boom—but the CEO keeps buying, institutions still dominate the float, and shorts are piled in. Here’s why ENPH might be starting to sync back in—and what investors should really watch. 🌞🔋